快加速器官网

快加速器官网

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

快加速器官网

Learn More
Folded page of a newspaper

快加速器官网

快加速器官网

Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results

快加速器官网

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

快加速器官网

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

快加速器官网

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

快加速器官网

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

快加速器官网

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

shadowrockey免费节点  推特网页版  free加速器安卓  雷光加速器官网下载  天行加速噐  高速节点  佛跳墙windowsban下载  快连ios下载官网